scispace - formally typeset
M

Morag Chisholm

Researcher at Southampton General Hospital

Publications -  12
Citations -  195

Morag Chisholm is an academic researcher from Southampton General Hospital. The author has contributed to research in topics: Protein C deficiency & Cryoprecipitate. The author has an hindex of 8, co-authored 12 publications receiving 189 citations.

Papers
More filters
Journal ArticleDOI

A base substitution (T-->C) in codon 29 of the alpha 2-globin gene causes alpha thalassaemia.

TL;DR: Three individuals of Greek or Greek Cypriot origin with an atypical form of HbH disease characterized by a severe hypochromic microcytic anaemia associated with relatively small amounts of HBH in the peripheral blood are identified.
Journal ArticleDOI

Further evidence for the importance of an androgen response element in the factor IX promoter

TL;DR: A case history and functional data are presented on another 48‐year‐old severe haemophilia B patient (UK232) with a different (G → A) mutation at the same position, −26, which strengthens the evidence for the importance of nucleotide −26 for the normal transcription of the gene in response to HNF4 and for the proposed Leyden recovery mechanism in responded to AR and testosterone acting directly through the factor IX ARE.
Journal ArticleDOI

Reversal of coagulopathy in Kasabach‐Merritt syndrome with tranexamic acid

TL;DR: An infant with a giant cavernous haemangioma developed a severe consumption coagulopathy and systemic bleeding, and replacement therapy with cryoprecipitate produced only a transient improvement in the abnormal clotting, but the addition of tranexamic acid resulted in sustained correction, permitting corrective surgery to be performed.
Journal ArticleDOI

Gastro-intestinal bleeding in acquired von Willebrand's disease: efficacy of high-dose immuno-globulin where substitution treatments failed.

TL;DR: A case of acquired von Willebrand's disease with severe and persistent gastro‐intestinal bleeding from multiple bleeding points is reported and the patient received maximum substitution treatment including factor VIII concentrates, cryoprecipitate and platelets.
Journal ArticleDOI

Protein c deficiency and stroke in early life

TL;DR: The suggestion that heterozygous protein C deficiency contributes to the risk of arterial stroke was not supported by this study.